2021
DOI: 10.4103/2045-9912.314330
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of xenon anesthesia in preventing postoperative cognitive dysfunction after cardiac and major non-cardiac surgeries in elderly patients: a topical review

Abstract: Elderly patients undergoing major cardiac and non-cardiac surgeries have a high propensity (up to 40–60%) of developing postoperative cognitive dysfunction, which are caused by patient’s factors, type of surgery, intraoperative and postoperative factors. All these pose a challenge to the clinicians. The noble gas xenon does not undergo metabolism or any kind of biotransformation in the body owing to its inert nature. Xenon confers excellent hemodynamic stability and provides excellent recovery at the end of su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 30 publications
0
4
0
Order By: Relevance
“…An alternative mechanism for the reduction in postoperative complications with xenon anesthesia is an improvement in end-organ perfusion due to greater hemodynamic stability. 26 33 Participants in the xenon group in our study maintained a mean arterial pressure significantly closer to their baseline and received significantly less ephedrine than those in the sevoflurane group ( Table 1 ). Despite this, the release in neural biomarkers was similar in both groups.…”
Section: Discussionmentioning
confidence: 80%
See 1 more Smart Citation
“…An alternative mechanism for the reduction in postoperative complications with xenon anesthesia is an improvement in end-organ perfusion due to greater hemodynamic stability. 26 33 Participants in the xenon group in our study maintained a mean arterial pressure significantly closer to their baseline and received significantly less ephedrine than those in the sevoflurane group ( Table 1 ). Despite this, the release in neural biomarkers was similar in both groups.…”
Section: Discussionmentioning
confidence: 80%
“… 25 A recent review identified potential benefits of xenon anesthesia such as hemodynamic stability and cytoprotection as being particularly beneficial in the elderly surgical population. 26 …”
Section: Introductionmentioning
confidence: 99%
“…Xenon is a novel popular volatile anesthetic in the operating room in recent years. With an extremely low blood gas coefficient (0.115) ( Nair et al, 2021 ), it has a fast onset of action and quick recovery in VA. Yet, several large RCTs ( Coburn et al, 2018 ; Al Tmimi et al, 2020 ) reported no difference between xenon and volatile anesthetics concerning the risk of delirium after cardiac surgery or hip fracture surgery.…”
Section: Discussionmentioning
confidence: 99%
“…Xenon (Xe) is an inert, colorless, odorless, heavy gas, and was discovered in 1898 [9]. Previous studies have reported that Xe at a subanesthetic concentration can protect from neuronal damage caused by cerebral ischemia, spinal cord ischemia and traumatic brain injury [10], and improve surgery-related cognitive impairment in elderly patients [11]. Furthermore, Xe can synergistically enhance the neuroprotective effect of mild hypothermia [12].…”
Section: Introductionmentioning
confidence: 99%